GALECTIN-3 SHAPES TOXIC ALPHA-SYNUCLEIN AGGREGATES IN PARKINSON´S DISEASE

• Juan Garcia-Revilla,
• Antonio Boza-Serrano,
• Yiyun Yin,
• Devkee Vadukul,
• Jesús Soldán Hidalgo,
• Lluís Camprubí-Ferrer,
• Marta Garcia Cruzado,
• Isak Martinsson,
• Oxana Klementieva,
• Rocío Ruiz,
• Francesco Aprile,
• Tomas Deierborg,
• José Luis Venero

Affiliations

Juan Garcia-Revilla

Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Instituto De Biomedicina De Sevilla, Sevilla, Spain; Lund University, Experimental Neuroinflammation Laboratory, Department Of Experimental Medical Science, Lund, Sweden; Universidad de Sevilla, Bioquímica Y Biología Molecular, Sevilla, Spain

Antonio Boza-Serrano

Universidad de Sevilla, Department Of Biochemistry And Molecular Biology, Sevilla, Spain; University of Lund, Department Of Experimental Medical Science, Lund, Sweden

Yiyun Yin

Imperial College London, Department Of Chemistry, Molecular Sciences Research Hub, London, United Kingdom

Devkee Vadukul

Imperial College London, Department Of Chemistry, Molecular Sciences Research Hub, London, United Kingdom

Jesús Soldán Hidalgo

Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Instituto De Biomedicina De Sevilla, Sevilla, Spain; Universidad de Sevilla, Bioquímica Y Biología Molecular, Seville, Spain

Lluís Camprubí-Ferrer

University of Lund, Department Of Experimental Medical Science, Lund, Sweden

Marta Garcia Cruzado

University of Lund, Department Of Experimental Medical Science, Lund, Sweden

Isak Martinsson

University of Lund, Department Of Experimental Medical Science, Lund, Sweden

Oxana Klementieva

Lund University, 6 Experimental Dementia Research Group, Department Of Experimental Medical Science, Sra: Nanolund, Multipark, Lund, Sweden

Rocío Ruiz

Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Instituto De Biomedicina De Sevilla, Sevilla, Spain; Universidad de Sevilla, Bioquímica Y Biología Molecular, Seville, Spain

Francesco Aprile

Imperial College London, Department Of Chemistry, Molecular Sciences Research Hub, London, United Kingdom; Imperial College London, Institute Of Chemical Biology, Molecular Sciences Research Hub', London, United Kingdom

Tomas Deierborg

University of Lund, Department Of Experimental Medical Science, Lund, Sweden

José Luis Venero

Hospital Universitario Virgen del Rocio/CSIC/Universidad de Sevilla, Instituto De Biomedicina De Sevilla, Sevilla, Spain; Universidad de Sevilla, Department Of Biochemistry And Molecular Biology, Sevilla, Spain